Page 9 - OHKF_Biotech_EN
P. 9
and link certain government fundings with universities’ performance the Loop to instigate reforms. We recommend that the Shenzhen
under the framework, thereby incentivising university researchers to Municipal Government first seek the approval of the Central
engage in knowledge transfer activities; 2) universities in Hong Kong Government on implementing comprehensive authorisation in the
should revise regulations on researchers engaging in outside work Loop, and that the Hong Kong and Shenzhen governments also
to increase hours available for knowledge transfer activities so as jointly seek the authorisation of various Ministries and Departments
to facilitate their engagement in cross-border activities; and 3) to implement pilot policies in biotech reform. Meanwhile, appropriate
universities should also provide courses geared towards the training fault tolerance mechanisms and effective incentivising measures
of multi-skilled talent with backgrounds in biotech and business, should be put in place in the Loop to ensure the successful
with a view to closing the talent gap on business operations and implementation of comprehensive authorisation. A biotech expert
investment in the biotech industry. advisory committee consisting of top-notch professionals within
China and from overseas should be established in the Loop to put
forward specific recommendations on the development of the
Recommendation 5 Strengthening
coordination and seeking comprehensive biotech industry, as well as exploring issues like ethics review
authorisation procedures, mutual recognition of results in clinical trials, drug
application review and approval procedures, etc.
Despite the high-level framework provided by the Office of the
Leading Group for the Development of the GBA, policy oversight Recommendation 6 Bridging the two cities’
and coordination between the two cities are still insufficient, systems and regimes
marked by the absence of a coordinated development plan for
“one zone, two parks”. We therefore recommend the The competent Central authorities should work on smoothing out
establishment of a relevant body, designated channel or platform differences in the two cities’ systems and regimes. In terms of market
under the Leading Group framework to provide oversight and access, Hong Kong does not place any restrictions on Mainland
coordination of the Loop’s development under the “one zone, two enterprises, but the Mainland subjects Hong Kong enterprises to
parks” arrangement, and expedite the formulation of a HK-SZ restrictions by means of a negative list. We therefore recommend that
“Joint Policy Package” that encompasses a range of issues like the National Development and Reform Commission and the Ministry
attraction of top-notch talent, movement of researchers, of Commerce ease restrictions on the negative list in relation to
management of organisations, capital flow and opening up of foreign capital accessing the stem cell, genetic diagnostics, and
the network, etc. therapy markets, and allow direct entry to the Mainland market by
Hong Kong biotech enterprises that are registered in the Loop and
In order to create a pilot and demonstration area for HK-SZ have Hong Kong permanent residents of Chinese nationality serving
collaboration in biotech, more autonomy should be conferred to
as a legal person or major shareholder, and treat said enterprises as if
they were domestically-owned enterprises.
7